@seydouboy.0:

seydou
seydou
Open In TikTok:
Region: SN
Monday 21 September 2026 21:02:47 GMT
1044
188
28
1

Music

Download

Comments

metzaderdeche1
METZA DERDECHE 763 Nar bi🧸✌🏾 :
63 seul ✌🏽
2026-10-06 02:18:17
0
ibrahima424p0
ibrahima424p0 :
🥰🥰🥰
2026-11-03 15:27:35
0
becayecisse161
BECAYE Cisse :
🥰🥰🥰🥰
2026-10-25 10:16:43
0
amdy.dxi.440
Amdy DXI 440 :
🥹🥹🥹🥹🥹
2026-10-20 02:50:52
0
aliou.sall0233
Aliou sall :
♥️♥️♥️
2026-10-17 11:33:49
0
yorosa3
yoro sarr :
🥰🥰🥰
2026-10-16 20:49:15
0
ndiagaeuro77
NDIAGA AURO 💸🚛🛣🇸🇳 :
❤️❤️❤️
2026-10-13 12:10:10
0
latendaye221
Lateyave221 :
🥰🥰🥰
2026-10-05 21:53:39
0
momoba418
MOMO NOREYNI 👌 :
🥰🥰🥰
2026-10-02 04:50:32
0
khadimeguabou2
khadimeguabou2 :
[J'aime][J'aime][J'aime]
2026-09-29 15:48:01
0
sambasylla9698
sambasylla9698 :
❤️❤️❤️
2026-09-24 01:19:45
0
khalilleboys0
khalille boys :
❤️❤️❤️
2026-09-23 14:18:14
0
boromdeukebi
KARARA :
❤️❤️❤️
2026-09-22 22:30:28
0
user2115308432936
user2115308432936 :
🥰🥰🥰
2026-09-22 20:45:56
0
fayedix24
faye Dxi 406 EEV 3 13 :
[Cœur rouge][Cœur rouge][Cœur rouge]
2026-09-22 17:52:17
0
metzambaye
Le Routier International 🇲🇦✪ :
❤️❤️❤️
2026-09-22 16:33:29
0
momo313____
momo313 :
✌️✌️✌️
2026-09-22 12:06:46
0
user5936804812518
ABDUL AZIZ SOW :
[Réconfortant][Réconfortant][Réconfortant]
2026-09-22 08:42:12
0
fallmodou18
fall Modou :
👌👌👌
2026-09-22 08:33:32
0
dabakh.malick325
dabakh malick :
🥰🥰🥰
2026-09-22 01:49:28
0
user18666005077757
user18666005077757 :
🥰🥰🥰
2026-09-21 22:59:43
0
fallouloum39
Fallou 1211 :
🥰🥰🥰
2026-09-21 22:03:49
0
babandiaye632
baba ndiaye :
🇸🇳🇸🇳🇸🇳
2026-09-21 22:03:28
0
gayo.ba.437
gayo ba 437 :
🥰🥰🥰
2026-09-21 21:35:38
0
abdou.chauffeur.s8
Abdou Chauffeur Sénégal 🚗🇸🇳 :
😁😁😁
2026-09-21 21:11:44
0
To see more videos from user @seydouboy.0, please go to the Tikwm homepage.

Other Videos

You take a GLP-1, and two headlines land on your feed. The FDA warns about rare vision loss. A new study links stopping a GLP-1 to heart attacks, strokes, or death. So what are you supposed to do about your next dose? Here’s what I want you to take home 👇🏾 1️⃣ The eye condition is rare, but the symptoms are urgent. The FDA flagged a possible increase in nonarteritic anterior ischemic optic neuropathy (NAION). It happens when blood flow to the optic nerve, which carries signals from your eye to your brain, is reduced. Across the trials the FDA reviewed, the rates were about 6 cases per 100,000 people per year in the GLP-1 group and 4 per 100,000 per year in the comparison groups. That’s a difference of about 2 cases per 100,000 people per year. 2️⃣ The stopping study looked at people with type 2 diabetes. Among more than 80,000 adults with type 2 diabetes and no prior cardiovascular disease, those who stopped had more heart attacks, strokes, or deaths combined. Researchers looked back at health records, so the study found a link and couldn’t tell whether stopping itself caused the difference. So what do you do? If the headlines are making you rethink your next dose and you’re feeling well, keep taking your medication as prescribed and bring your questions to your prescriber. If you need to stop, ask what the plan is for managing your blood sugar and heart risk. If vision in one eye suddenly goes dark, gets blurry, or develops a blind spot, get emergency care right away, even if it doesn’t hurt. Save this so you know what to watch for. Follow for practical hospital tips and medical updates that affect you. For general education. Talk with your prescriber about your individual treatment plan. Studies: -FDA safety communication on GLP-1s and rare vision loss (NAION)⁠ -The Lancet Regional Health – Europe study on stopping GLP-1s in people with type 2 diabetes⁠ #g#glp1g#glp1sicknessn#naiond#diabetes
You take a GLP-1, and two headlines land on your feed. The FDA warns about rare vision loss. A new study links stopping a GLP-1 to heart attacks, strokes, or death. So what are you supposed to do about your next dose? Here’s what I want you to take home 👇🏾 1️⃣ The eye condition is rare, but the symptoms are urgent. The FDA flagged a possible increase in nonarteritic anterior ischemic optic neuropathy (NAION). It happens when blood flow to the optic nerve, which carries signals from your eye to your brain, is reduced. Across the trials the FDA reviewed, the rates were about 6 cases per 100,000 people per year in the GLP-1 group and 4 per 100,000 per year in the comparison groups. That’s a difference of about 2 cases per 100,000 people per year. 2️⃣ The stopping study looked at people with type 2 diabetes. Among more than 80,000 adults with type 2 diabetes and no prior cardiovascular disease, those who stopped had more heart attacks, strokes, or deaths combined. Researchers looked back at health records, so the study found a link and couldn’t tell whether stopping itself caused the difference. So what do you do? If the headlines are making you rethink your next dose and you’re feeling well, keep taking your medication as prescribed and bring your questions to your prescriber. If you need to stop, ask what the plan is for managing your blood sugar and heart risk. If vision in one eye suddenly goes dark, gets blurry, or develops a blind spot, get emergency care right away, even if it doesn’t hurt. Save this so you know what to watch for. Follow for practical hospital tips and medical updates that affect you. For general education. Talk with your prescriber about your individual treatment plan. Studies: -FDA safety communication on GLP-1s and rare vision loss (NAION)⁠ -The Lancet Regional Health – Europe study on stopping GLP-1s in people with type 2 diabetes⁠ #g#glp1g#glp1sicknessn#naiond#diabetes

About